International Biotechnology Trust PLC Ultragenyx Pharmaceutical Inc. Transaction History

International Biotechnology Trust PLC

$295 Million
Q3 2023

A detailed history of International Biotechnology Trust PLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, International Biotechnology Trust PLC holds 250,052 shares of RARE stock, worth $10.9 Million. This represents 3.03% of its overall portfolio holdings.

Number of Shares

250,052

Previous 80,052 212.36%

Holding current value

$10.9 Million

Previous $3.69 Million 141.44%

% of portfolio

3.03%

Previous 1.15%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$34.92 - $46.66 $5.94 Million - $7.93 Million	170,000 Added 212.36%	250,052 $8.91 Million
Q2 2023 Aug 08, 2023	SELL	$37.35 - $52.15 $6.87 Million - $9.6 Million	-184,000 Reduced 69.68%	80,052 $3.69 Million
Q1 2023 May 18, 2023	BUY	$36.99 - $48.71 $3.33 Million - $4.38 Million	90,000 Added 51.71%	264,052 $10.6 Million
Q3 2022 Nov 08, 2022	BUY	$39.96 - $66.14 $6.57 Million - $10.9 Million	164,442 Added 1711.16%	174,052 $7.2 Million
Q2 2022 Aug 16, 2022	SELL	$45.8 - $85.4 $10.2 Million - $19.1 Million	-223,490 Reduced 95.88%	9,610 $161 Million
Q1 2022 May 20, 2022	BUY	$62.2 - $84.4 $5.91 Million - $8.02 Million	95,000 Added 68.79%	233,100 $16.9 Million
Q4 2021 Feb 15, 2022	BUY	$73.71 - $87.86 $2.58 Million - $3.08 Million	35,000 Added 33.95%	138,100 $11.6 Million
Q3 2021 Nov 12, 2021	BUY	$77.92 - $102.4 $3.35 Million - $4.4 Million	43,000 Added 71.55%	103,100 $9.29 Million
Q2 2021 Aug 11, 2021	BUY	$92.19 - $115.71 $3.69 Million - $4.63 Million	40,000 Added 199.0%	60,100 $5.73 Million
Q1 2021 May 17, 2021	BUY	$106.9 - $167.73 $2.15 Million - $3.37 Million	20,100 New	20,100 $2.29 Million
Q2 2018 Aug 13, 2018	SELL	$48.54 - $85.31 $1.99 Million - $3.5 Million	-41,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$44.33 - $58.52 $1.82 Million - $2.4 Million	41,000 New	41,000 $2.09 Million

Others Institutions Holding RARE

# of Institutions

325

Shares Held

85.6M

Call Options Held

520K

Put Options Held

406K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.06B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

News

Stay updated on International Biotechnology Trust PLC with notifications on news.

Account

International Biotechnology Trust PLC Ultragenyx Pharmaceutical Inc. Transaction History